BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wipperman MF, Bhattarai SK, Vorkas CK, Maringati VS, Taur Y, Mathurin L, McAulay K, Vilbrun SC, Francois D, Bean J, Walsh KF, Nathan C, Fitzgerald DW, Glickman MS, Bucci V. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nat Commun 2021;12:1141. [PMID: 33602926 DOI: 10.1038/s41467-021-21475-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gong W, Wu X. Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy. Front Microbiol 2021;12:745592. [PMID: 34745048 DOI: 10.3389/fmicb.2021.745592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ding X, Zhou J, Chai Y, Yan Z, Liu X, Dong Y, Mei X, Jiang Y, Lei H. A metagenomic study of the gut microbiome in PTB'S disease. Microbes Infect 2021;:104893. [PMID: 34710620 DOI: 10.1016/j.micinf.2021.104893] [Reference Citation Analysis]
3 de Araujo LS, Ribeiro-Alves M, Wipperman MF, Vorkas CK, Pessler F, Saad MHF. Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response. Cells 2021;10:2704. [PMID: 34685683 DOI: 10.3390/cells10102704] [Reference Citation Analysis]
4 Pacheco I, Díaz-Sánchez S, Contreras M, Villar M, Cabezas-Cruz A, Gortázar C, de la Fuente J. Probiotic Bacteria with High Alpha-Gal Content Protect Zebrafish against Mycobacteriosis. Pharmaceuticals (Basel) 2021;14:635. [PMID: 34208966 DOI: 10.3390/ph14070635] [Reference Citation Analysis]
5 Comberiati P, Di Cicco M, Paravati F, Pelosi U, Di Gangi A, Arasi S, Barni S, Caimmi D, Mastrorilli C, Licari A, Chiera F. The Role of Gut and Lung Microbiota in Susceptibility to Tuberculosis. Int J Environ Res Public Health 2021;18:12220. [PMID: 34831976 DOI: 10.3390/ijerph182212220] [Reference Citation Analysis]
6 Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive MC, Dutta P, Mutaawe S, Anya O, Meza-Segura M, Moormann AM, Ward DV, McCormick BA, Bucci V. Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight 2021;6:e152346. [PMID: 34403368 DOI: 10.1172/jci.insight.152346] [Reference Citation Analysis]
7 Peng W, Li H, Zhao X, Shao B, Zhu K. Pyocyanin Modulates Gastrointestinal Transformation and Microbiota. J Agric Food Chem 2022. [PMID: 35171599 DOI: 10.1021/acs.jafc.1c07726] [Reference Citation Analysis]
8 Fucic A, Mantovani A, Ten Tusscher GW. Immuno-Hormonal, Genetic and Metabolic Profiling of Newborns as a Basis for the Life-Long OneHealth Medical Record: A Scoping Review. Medicina (Kaunas) 2021;57:382. [PMID: 33920921 DOI: 10.3390/medicina57040382] [Reference Citation Analysis]
9 Shah T, Shah Z, Baloch Z, Cui X. The role of microbiota in respiratory health and diseases, particularly in tuberculosis. Biomed Pharmacother 2021;143:112108. [PMID: 34560539 DOI: 10.1016/j.biopha.2021.112108] [Reference Citation Analysis]
10 Neto CC, Mortzfeld BM, Turbitt JR, Bhattarai SK, Yeliseyev V, DiBenedetto N, Bry L, Bucci V. Proanthocyanidin-enriched cranberry extract induces resilient bacterial community dynamics in a gnotobiotic mouse model. Microb Cell 2021;8:131-42. [PMID: 34055966 DOI: 10.15698/mic2021.06.752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]